Navigation Links
Abbott Executive Jim Tyree Takes IBIO Helm

Chicago, IL - The recent Chicago biotech festivals weren't the only indicators that biotech in Illinois is finally coming of age.

That same week, the Illinois Biotechnology Industry Organization (IBIO) elected as its new chairman Jim L. Tyree, vice ......

Full article >>> part of a cadre of people who started the original Chicago Biotechnology Network Association (CBN) in 1997, which was the first biotech organization in the area. CBN, a Chicagoland organization, sought to bring together emerging companies and academia under one roof with a common goal: a group of people faced with the problem of how to make a go of biotech in a region that wasn't a traditional bio......

Full article >>> is one of the leading states in the U.S. for these two key crops) as well as Monsanto, the top company in agricultural biotech.

Additionally, a growing need to educate legislators on the human and agricultural aspects of the biotech industry became apparent. In 2001, it soon became obvious that neither CBN nor the old IBIO had the cr......

Full article >>> lank">Neopharm, Ted Davis of Vector Fund Management, Tom Churchwell of ARCH Development and others. A meeting (held in Chicago and organized and chaired by Hogg at O'Hare Airport) called together all eight state biotech......

Full article >>> f="http://www.pyxisgenomics.com" target="_blank">Pyxis Genomics and Vijaya Vasista of Nanosphere.

The time was right to transition the chairman of the new IBIO to further involve Abbott, which is the top pharmaceutical company in the Midwest. Enter Tyree, a new recruit to the IBIO board early in 2002. ......

Full article >>> part of Pharmacia).

Tyree returned to Abbott and his Midwest roots once again in an assignment to manage Abbott's Japan operations. There, he utilized the experience he gained at Bristol-Myers Squibb in the world's second-largest country market. More recently, he assumed the responsibilities for its worldwide pharmaceutical business......

Full article >>> that's slightly smaller than California. It has about 4 million inhabitants (3 million in the north island and about 1 million in the south island). It has more than 50 million sheep. We met with the biotech communities in Auckland and Wellington in the north island and Dunedin and Christchurch in the south island.

Its biotech community soaked up information about the U.S. biotech commu......

Full article >>>
See you next week!
......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 04/14/03


Related biology technology :

1. Abbott vs. Thailand has implications for innovation and access
2. A prognosis for GE and Abbott Diagnostics
3. Wisconsin court halts Abbotts sale of genotyping products
4. Wisconsin court affirms damages in Innogenetics, Abbott patent case
5. Abbott Labs campus in Kenosha could send ripples through local biotech
6. Promega Announces Agreement with Abbott
7. Executives hear about promise, limits of RFID and nanotech
8. Interview: WTN Gets Real with Appletons Brad Hansen - Dot-Com Experience helps Executive to Spot Trends
9. An Overnight Business Success Takes 20 Years
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/11/2017)... ... October 11, 2017 , ... ... Andi Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief research ... Inc. has been selected for membership in ARCS Alumni Hall of Fame ...
(Date:10/11/2017)... CA, USA (PRWEB) , ... October 11, 2017 , ... ... to take place on 7th and 8th June 2018 in San Francisco, CA. The ... influencers as well as several distinguished CEOs, board directors and government officials from around ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. 11, ... Research, London (ICR) and University of ... SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma (MM), ... nine . The University of Leeds ... funded by Myeloma UK, and ICR will perform the testing ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
Breaking Biology Technology:
(Date:4/11/2017)... , April 11, 2017 NXT-ID, ... security technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate ... ... NXT-ID, we look forward to their guidance and benefiting from ...
(Date:4/5/2017)... April 5, 2017 Today HYPR Corp. ... the server component of the HYPR platform is officially ... the end-to-end security architecture that empowers biometric authentication across ... has already secured over 15 million users across the ... of connected home product suites and physical access represent ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
Breaking Biology News(10 mins):